Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02475213
Brief Title: Safety Study of Enoblituzumab (MGA271) in Combination With Pembrolizumab or MGA012 in Refractory Cancer

First Submitted : June 16, 2015
First Submitted that Met QC Criteria : June 16, 2015
First Posted : June 18, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : April 13, 2021
Last Update Posted : April 14, 2021